Although FGF21 had no impact on diabetes-induced cardiac ROS production increase (Fig. 2d), it remarkably improved ROS clearance by induction of multiple antioxidative genes (Fig. S6A−D) in the diabetic hearts, which are the downstream target genes of NRF2. The gene discussed is FGF21; the disease is diabetes mellitus.